Inhliziyo imithi - amaphilisi 'Riboksin'

Isithako asebenzayo we umuthi inosine. Sizohlola lo izidakamizwa itholakala amaphilisi. ithebhulethi ngasinye siqukethe 0,2 g isithako esisebenzayo. Njengoba izinto asizayo ukungezwa ingxube enamathela, ayi-calcium stearate, futhi amazambane isitashi.

Tablets "Riboxinum" - likuthola antihypoxic anti-arrhythmic isinyathelo Anabolic ejenti. Njengoba eyandulela ka ATP (adenosine triphosphate), umuthi abathintekayo umzimba glucose. Ezimweni hypoxic, futhi lapho lingekho ikhambi le-ATP "Riboxinum" ukhiqiza isenzo Iqalisa ngomhlaka umzimba pyruvic acid, ngaleyo ndlela kuqinisekiswe inqubo evamile kwezicubu kwezimila. Futhi, izidakamizwa kunomphumela omuhle ukusebenza xanthine dehydrogenase.

Yini enye elisitshela khona Riboksin "imiyalelo izidakamizwa 'ukusetshenziswa? Tablets zomuthi ikhuthaza umzimba myocardium. Lokhu kwandisa ibhalansi iseli amandla, kukhona ukukhuthazwa zamagama nucleotide, kwandisa umsebenzi enzyme ethile. Tablets "Riboxinum" ukuvumela phambili ku izinga myocardium, sandla contractile umsebenzi wayo, ukuphumula ephelele imisipha inhliziyo kusendlalelo diastole.

Lokhu kungenxa ikhono zomuthi ukuhlanganisa uxhumano nomsebenzisi calcium ion ukuthi ufake amaseli ujabule. Tablets "Riboxinum" asebenzayo ukukhuthaza izicubu ukuvuselelwa. Ikakhulukazi, umphumela izidakamizwa siqondiswe myocardium futhi nolwelwesi lwamafinyila we ipheshana wokugaya ukudla.

Mayelana ukusetshenziswa kwezidakamizwa "Riboksin" (amaphilisi), ukulaya icacisa udaba, ekhomba ukwelapha pathologies ezilandelayo:

• Ischemic isifo senhliziyo (IHD), isimo postinfarction angina. Kulezi zimo, umuthi isetshenziswa ekwelapheni.
• Senhliziyo glycoside ukudakwa.
• Zenhliziyo zasezindaweni ezihlukahlukene.
• Myocarditis.
• Inhliziyo isigqi thuthuva.

Futhi amalungiselelo eziyinkimbinkimbi aphathe ukukhubazeka ahlukahlukene inhliziyo, isifo sokuqina kwemithambo yegazi i-coronary, myocarditis nezinye izifo zenhliziyo. Ngaphezu kwalokho, i-nomuthi "Riboxinum" (amaphilisi) iyindlela ethuthukisa umsebenzi ezibukwayo. izakhiwo ezinjalo neqhaza ukulungiswa elisetshenziswa izifo ezifana glaucoma otkrytouglovaya.

Sebenzisa "Riboksin" amaphilisi ngendlela elandelayo: umthamo zonke izinsuku we ukuqokwa phakathi amadala izingane omdala iziguli kuyinto 0.6-2.4 amagremu. Izinsuku zokuqala ezimbili ngemva wezokwelapha esithathwayo kathathu noma kane ngosuku iphilisi elilodwa. Kusukela ngosuku lwesithathu yokwemukela uma izidakamizwa ibekezelelwe, umthamo luyanda 1.2 - 1.4 amagremu ngosuku. Isikhathi yokuyelapha kusukela ezinsukwini 28 kuya ezinyangeni ezintathu. Izibhebhe zithathwa ngaphambi kokudla.

Ngokuvamile lokhu izidakamizwa kahle ibekezelelwe. ukungabekezelelani ngamunye kungaba ukuzibonakalisa okweqa umthamo Kunconywa. Lubonakaliswa ukuminyana, ukulunywa livela. Esimeni izenzakalo ezinjalo ikhanseliwe imithi. Futhi, ezimweni ezingajwayelekile Kuye kwaphawulwa lapho ekwelapheni izidakamizwa egazini amazinga anda urea nazo akuvamile waphawula eziya ziba zimbi ka sifo emva kokwelashwa isikhathi eside nale ejenti.

Izimo ukusetshenziswa ayatholakala ngenhla egunjini lokuhlolwa kwezifo. Okungukuthi, sifo, futhi kanye hypersensitivity kuya izidakamizwa esebenzayo. Ngaphezu kwalokho, izidakamizwa is contraindicated ku hyperuricemia, kungagcini yokuvuma in iziguli esingamahlalakhona kwezinso.

Njengoba for izibuyekezo zakamuva ke ukuhluleka kwezinso e isiguli ethola izidakamizwa "Riboksin" wenzeka kanjani kunqunywa baqiniseka udokotela e yokuthi isidingo buyafaneleka. Eziphuthumayo iziyaluyalu zenhliziyo ukulungiswa akuyona kwenziwe ngosizo lokhu izidakamizwa.

Uma izidakamizwa "Riboxinum" (amaphilisi) isetshenziswa ngesikhathi esifanayo ne blocker β-adrenergic, umphumela walo hhayi ziyancipha. Ukusetshenziswa ahlangene we glycosides inhliziyo kusiza ukuvimbela kuwukubonakaliswa arrhythmias futhi ngakhula isinyathelo inotropic.